KEYNOTE SPEAKERS: Michael Karin
Professor, Pharmacology,
Tumor Growth Invasion & Metastasis,
UCSD FEATURED SPEAKER:
John Sims
Scientific Executive Director
Inflammation
Amgen DISTINGUISHED SPEAKERS:
Linda Burkly, Ph.D.
Distinguished Investigator
Biogen Idec, Inc.
Fabio Cominelli, M.D., Ph.D.
Chief, Division of Gastroenterology and Liver Disease
Case Western Reserve University
Director, CWRU/UH Digestive Health Center
University Hospitals of Cleveland
Raymond Donnelly
Senior Investigator
FDA
Scott Durum
Head, Cytokines and Immunity Section
Laboratory of Molecular Immunoregulation
NIH, NCI
Simon Fricker
Distinguished Scientific Fellow
Genzyme Corporation
Jane Grogen
Scientist
Genentech
Klaus Ley
Head, Inflammation Biology
La Jolla Institute for Allergy & Immunology
Xiaoxia Li
Staff, Department of Immunology
Lerner Research Institute
Cleveland Clinic
Haishan Lin, Ph.D.
Director of Immunology
Five Prime Therapeutics, Inc.
Marco Londei
Novartis
Erik Lubberts
Professor
University Hospital Nijmegen/Erasmus Medical Center
Mohamad Navab
Professor of Medicine, Cardiology
UCLA
Jay Rothstein
Director, Inflammation Research
Amgen
Benjamin Segal
Director, U-M Multiple Sclerosis Center
Director, Holtom-Garrett Program in Immunology
Professor, Neurology
University Of Michigan
Tom Schall
President and CEO
ChemoCentryx
Julian Symons, D. Phil
Head, HCV Biology
Roche
Barbara White
VP, Clinical Development
Inflammatory Disease
MedImmune
De Yang, Ph.D.
Laboratory of Molecular Immunoregulation
NCI, NIH |